NL-OMON44381已完成不适用
Open label, randomized, cross-over study to explore the pharmacokinetics of BAY 1834845 after oral and intravenous dosing, including food effect and absolute bioavailability (Part A), and to investigate the effect of BAY 1834845 on the pharmacokinetics of orally administered methotrexate (Part B) in healthy male subjects - BAY 1834845 FE, BA, Methotrexate DDI Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer AG
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male subjects
- •- 18 - 50 years, inclusive
- •- BMI: 18.0 - 30.0 kg/m², inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 3 months before the start of this study. In case of donating more than 0.5 liters of blood in the 4 week prior the start of this study.
研究者
相似试验
已完成
3 期
A randomised, open-label, cross-over study to examine the pharmacokinetics, and short-term safety and efficacy of two dosing strategies of raltegravir plus atazanavir in human immunodficiency virus (HIV)-infected patientschronic HIV infectionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12609000179235ational Centre in HIV Epidemiology/The University of New South Wales24
撤回
不适用
An open-label, randomized, crossover study to evaluate the pharmacokinetics, bioavailability, and bioequivalence following administration of JZP-507 oral solution and Xyrem®in healthy subjects.cataplexynarcolepsy10040998NL-OMON45490Jazz Pharmaceuticals60
已完成
不适用
Drug-drug Interaction Study(Lobeglitazone, Warfarin)Endocrine, nutritional and metabolic diseaseKCT0000999Chong Kun Dang24
已完成
1 期
To estimate the bioavailability (amount of drug which reaches the blood) of GRC 17536 following oral administration in normal healthy male adults.CTRI/2014/12/005320Glenmark Pharmaceuticals SA60
进行中（未招募）
不适用
Patient preferences for Eucreas® versus Victoza® in Type 2 Diabetes mellitus patientstype 2 diabetes mellitusMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-003818-16-DEovartis Pharma GmbH